Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suma Babu

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Muscle & Nerve|March 21, 2025
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral SclerosisGrace Addy, Erica Scirocco, Dario Gelevski, et al.
Muscle & Nerve|June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform TrialEric A Macklin, James D Berry, Brittney A Harkey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Neuroimage. Clinical|May 21, 2021
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trialSuma Babu, Baileigh G Hightower, James Chan, et al.
Muscle & Nerve|November 21, 2018
A pilot trial of RNS60 in amyotrophic lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Sarah Luppino, et al.
Neurology and Therapy|October 17, 2023
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS SummitRita Sattler, Bryan J Traynor, Janice Robertson, et al.
Muscle & Nerve|June 29, 2022
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitorMegan Yerton, Allison Winter, Anthony Kostov, et al.
The New England Journal of Medicine|September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALSTimothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Muscle & Nerve|March 17, 2023
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)Megan Yerton, Allison Winter, Dario Gelevski, et al.
Muscle & Nerve|June 13, 2026
Optimizing Research Operations and Resource Utilization in ALS Care: Insights From the Tofersen Antisense Oligonucleotide Expanded Access ProtocolAlison Wheeler, Kush Mehta, Danica Sanders, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Muscle & Nerve|March 21, 2025
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral SclerosisGrace Addy, Erica Scirocco, Dario Gelevski, et al.
Muscle & Nerve|June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform TrialEric A Macklin, James D Berry, Brittney A Harkey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Neuroimage. Clinical|May 21, 2021
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trialSuma Babu, Baileigh G Hightower, James Chan, et al.
Muscle & Nerve|November 21, 2018
A pilot trial of RNS60 in amyotrophic lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Sarah Luppino, et al.
Neurology and Therapy|October 17, 2023
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS SummitRita Sattler, Bryan J Traynor, Janice Robertson, et al.
Muscle & Nerve|June 29, 2022
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitorMegan Yerton, Allison Winter, Anthony Kostov, et al.
The New England Journal of Medicine|September 21, 2022
Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALSTimothy M Miller, Merit E Cudkowicz, Angela Genge, et al.
Muscle & Nerve|March 17, 2023
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)Megan Yerton, Allison Winter, Dario Gelevski, et al.
Muscle & Nerve|June 13, 2026
Optimizing Research Operations and Resource Utilization in ALS Care: Insights From the Tofersen Antisense Oligonucleotide Expanded Access ProtocolAlison Wheeler, Kush Mehta, Danica Sanders, et al.
Pageof 6